AGL Quote, Financials, Valuation and Earnings

CVS Health Corp. has a net margin of -12.04% compared to Agilon Health, Inc.'s net margin of 2.77%. Agilon Health, Inc.'s return on equity of -111.79% beat CVS Health Corp.'s return on equity of 2.28%.

Agilon Health, Inc. has a consensus price target of $21.56, signalling upside risk potential of 100.77%. On the other hand CVS Health Corp. has an analysts' consensus of $96.42 which suggests that it could grow by 31.21%. Given that Agilon Health, Inc. has higher upside potential than CVS Health Corp., analysts believe Agilon Health, Inc. is more attractive than CVS Health Corp..

Agilon Health, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison CVS Health Corp. has a beta of 0.511, suggesting its less volatile than the S&P 500 by 48.916%.

Agilon Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CVS Health Corp. offers a yield of 3.57% to investors and pays a quarterly dividend of $0.67 per share. Agilon Health, Inc. pays -- of its earnings as a dividend. CVS Health Corp. pays out 191.23% of its earnings as a dividend.

Agilon Health, Inc. quarterly revenues are $1.6B, which are smaller than CVS Health Corp. quarterly revenues of $105.7B. Agilon Health, Inc.'s net income of -$188.9M is lower than CVS Health Corp.'s net income of $2.9B. Notably, Agilon Health, Inc.'s price-to-earnings ratio is -- while CVS Health Corp.'s PE ratio is 53.85x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Agilon Health, Inc. is 0.21x versus 0.24x for CVS Health Corp.. Usually stocks with elevated PS ratios are considered overvalued.

InnovAge Holding Corp. has a net margin of -12.04% compared to Agilon Health, Inc.'s net margin of 4.93%. Agilon Health, Inc.'s return on equity of -111.79% beat InnovAge Holding Corp.'s return on equity of 1.21%.

Agilon Health, Inc. has a consensus price target of $21.56, signalling upside risk potential of 100.77%. On the other hand InnovAge Holding Corp. has an analysts' consensus of $7.00 which suggests that it could fall by -8.02%. Given that Agilon Health, Inc. has higher upside potential than InnovAge Holding Corp., analysts believe Agilon Health, Inc. is more attractive than InnovAge Holding Corp..

Agilon Health, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison InnovAge Holding Corp. has a beta of 0.503, suggesting its less volatile than the S&P 500 by 49.705%.

Agilon Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. InnovAge Holding Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Agilon Health, Inc. pays -- of its earnings as a dividend. InnovAge Holding Corp. pays out -- of its earnings as a dividend.

Agilon Health, Inc. quarterly revenues are $1.6B, which are larger than InnovAge Holding Corp. quarterly revenues of $239.7M. Agilon Health, Inc.'s net income of -$188.9M is lower than InnovAge Holding Corp.'s net income of $11.8M. Notably, Agilon Health, Inc.'s price-to-earnings ratio is -- while InnovAge Holding Corp.'s PE ratio is 155.70x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Agilon Health, Inc. is 0.21x versus 1.07x for InnovAge Holding Corp.. Usually stocks with elevated PS ratios are considered overvalued.

National HealthCare Corp. has a net margin of -12.04% compared to Agilon Health, Inc.'s net margin of 6.55%. Agilon Health, Inc.'s return on equity of -111.79% beat National HealthCare Corp.'s return on equity of 11.91%.

Agilon Health, Inc. has a consensus price target of $21.56, signalling upside risk potential of 100.77%. On the other hand National HealthCare Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that Agilon Health, Inc. has higher upside potential than National HealthCare Corp., analysts believe Agilon Health, Inc. is more attractive than National HealthCare Corp..

Agilon Health, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison National HealthCare Corp. has a beta of 0.581, suggesting its less volatile than the S&P 500 by 41.939%.

Agilon Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. National HealthCare Corp. offers a yield of 1.53% to investors and pays a quarterly dividend of $0.64 per share. Agilon Health, Inc. pays -- of its earnings as a dividend. National HealthCare Corp. pays out 32.98% of its earnings as a dividend. National HealthCare Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Agilon Health, Inc. quarterly revenues are $1.6B, which are larger than National HealthCare Corp. quarterly revenues of $384.8M. Agilon Health, Inc.'s net income of -$188.9M is lower than National HealthCare Corp.'s net income of $25.2M. Notably, Agilon Health, Inc.'s price-to-earnings ratio is -- while National HealthCare Corp.'s PE ratio is 21.87x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Agilon Health, Inc. is 0.21x versus 1.74x for National HealthCare Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Sonida Senior Living, Inc. has a net margin of -12.04% compared to Agilon Health, Inc.'s net margin of -30.87%. Agilon Health, Inc.'s return on equity of -111.79% beat Sonida Senior Living, Inc.'s return on equity of -72.2%.

Agilon Health, Inc. has a consensus price target of $21.56, signalling upside risk potential of 100.77%. On the other hand Sonida Senior Living, Inc. has an analysts' consensus of $34.00 which suggests that it could grow by 5.66%. Given that Agilon Health, Inc. has higher upside potential than Sonida Senior Living, Inc., analysts believe Agilon Health, Inc. is more attractive than Sonida Senior Living, Inc..

Agilon Health, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Sonida Senior Living, Inc. has a beta of 0.746, suggesting its less volatile than the S&P 500 by 25.381%.

Agilon Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Sonida Senior Living, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Agilon Health, Inc. pays -- of its earnings as a dividend. Sonida Senior Living, Inc. pays out 85.92% of its earnings as a dividend. Sonida Senior Living, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Agilon Health, Inc. quarterly revenues are $1.6B, which are larger than Sonida Senior Living, Inc. quarterly revenues of $97.7M. Agilon Health, Inc.'s net income of -$188.9M is lower than Sonida Senior Living, Inc.'s net income of -$30.1M. Notably, Agilon Health, Inc.'s price-to-earnings ratio is -- while Sonida Senior Living, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Agilon Health, Inc. is 0.21x versus 1.53x for Sonida Senior Living, Inc.. Usually stocks with elevated PS ratios are considered overvalued.